drugset / Trial / NCT01304394

Safety During Use of Paediatric Triple Chamber Bag Formulas

NCT01304394 ↗

Phase 3 Completed 161 enrolled Baxter Healthcare Corporation
NaSingle-groupOpen-labelTreatment

Summary

The primary objective of this study was to provide daily information on the performance safety of the Ped3CB in practical therapeutic use in pediatric patients.

Timeline

Start
2008-02
Primary completion
2008-12
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Ped3CB Unknown — Intravenous